These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
208 related items for PubMed ID: 22672904
1. Repression of endometrial tumor growth by targeting SREBP1 and lipogenesis. Li W, Tai Y, Zhou J, Gu W, Bai Z, Zhou T, Zhong Z, McCue PA, Sang N, Ji JY, Kong B, Jiang J, Wang C. Cell Cycle; 2012 Jun 15; 11(12):2348-58. PubMed ID: 22672904 [Abstract] [Full Text] [Related]
2. Sterol regulatory element-binding protein 1 is required for ovarian tumor growth. Nie LY, Lu QT, Li WH, Yang N, Dongol S, Zhang X, Jiang J. Oncol Rep; 2013 Sep 15; 30(3):1346-54. PubMed ID: 23818099 [Abstract] [Full Text] [Related]
3. SIRT1 promotes endometrial tumor growth by targeting SREBP1 and lipogenesis. Lin L, Zheng X, Qiu C, Dongol S, Lv Q, Jiang J, Kong B, Wang C. Oncol Rep; 2014 Dec 15; 32(6):2831-5. PubMed ID: 25270091 [Abstract] [Full Text] [Related]
4. BF175 inhibits endometrial carcinoma through SREBP-regulated metabolic pathways in vitro. Wang Q, Hu R, Li W, Tai Y, Gu W, Das BC, Yang F, Ji J, Wang C, Zhou J. Mol Cell Endocrinol; 2021 Mar 01; 523():111135. PubMed ID: 33359761 [Abstract] [Full Text] [Related]
5. Activation of sterol regulatory element-binding protein 1 (SREBP1)-mediated lipogenesis by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma. Lo AK, Lung RW, Dawson CW, Young LS, Ko CW, Yeung WW, Kang W, To KF, Lo KW. J Pathol; 2018 Oct 01; 246(2):180-190. PubMed ID: 29968360 [Abstract] [Full Text] [Related]
6. An AKT/PRMT5/SREBP1 axis in lung adenocarcinoma regulates de novo lipogenesis and tumor growth. Liu L, Yan H, Ruan M, Yang H, Wang L, Lei B, Sun X, Chang C, Huang G, Xie W. Cancer Sci; 2021 Aug 01; 112(8):3083-3098. PubMed ID: 34033176 [Abstract] [Full Text] [Related]
7. α-Mangostin suppresses the de novo lipogenesis and enhances the chemotherapeutic response to gemcitabine in gallbladder carcinoma cells via targeting the AMPK/SREBP1 cascades. Shi Y, Fan Y, Hu Y, Jing J, Wang C, Wu Y, Geng Q, Dong X, Li E, Dong D. J Cell Mol Med; 2020 Jan 01; 24(1):760-771. PubMed ID: 31762191 [Abstract] [Full Text] [Related]
8. Sterol regulatory element binding protein-1 (SREBP1) gene expression is similarly increased in polycystic ovary syndrome and endometrial cancer. Shafiee MN, Mongan N, Seedhouse C, Chapman C, Deen S, Abu J, Atiomo W. Acta Obstet Gynecol Scand; 2017 May 01; 96(5):556-562. PubMed ID: 28176325 [Abstract] [Full Text] [Related]
9. The effect of feed restriction on expression of hepatic lipogenic genes in broiler chickens and the function of SREBP1. Wang PH, Ko YH, Chin HJ, Hsu C, Ding ST, Chen CY. Comp Biochem Physiol B Biochem Mol Biol; 2009 Aug 01; 153(4):327-31. PubMed ID: 19383549 [Abstract] [Full Text] [Related]
10. Overexpression of SREBP1 (sterol regulatory element binding protein 1) promotes de novo fatty acid synthesis and triacylglycerol accumulation in goat mammary epithelial cells. Xu HF, Luo J, Zhao WS, Yang YC, Tian HB, Shi HB, Bionaz M. J Dairy Sci; 2016 Jan 01; 99(1):783-95. PubMed ID: 26601584 [Abstract] [Full Text] [Related]
11. DDX39B facilitates the malignant progression of hepatocellular carcinoma via activation of SREBP1-mediated de novo lipid synthesis. Feng T, Li S, Zhao G, Li Q, Yuan H, Zhang J, Gu R, Ou D, Guo Y, Kou Q, Wang Q, Li K, Lin P. Cell Oncol (Dordr); 2023 Oct 01; 46(5):1235-1252. PubMed ID: 37052853 [Abstract] [Full Text] [Related]
12. Novel SREBP1 inhibitor cinobufotalin suppresses proliferation of hepatocellular carcinoma by targeting lipogenesis. Meng H, Shen M, Li J, Zhang R, Li X, Zhao L, Huang G, Liu J. Eur J Pharmacol; 2021 Sep 05; 906():174280. PubMed ID: 34174265 [Abstract] [Full Text] [Related]
14. Hepatocellular Carcinoma-Associated Protein TD26 Interacts and Enhances Sterol Regulatory Element-Binding Protein 1 Activity to Promote Tumor Cell Proliferation and Growth. Wang C, Tong Y, Wen Y, Cai J, Guo H, Huang L, Xu M, Feng M, Chen X, Zhang J, Wu H, Kong X, Xia Q. Hepatology; 2018 Nov 05; 68(5):1833-1850. PubMed ID: 29663480 [Abstract] [Full Text] [Related]
15. Silibinin inhibits endometrial carcinoma via blocking pathways of STAT3 activation and SREBP1-mediated lipid accumulation. Shi Z, Zhou Q, Gao S, Li W, Li X, Liu Z, Jin P, Jiang J. Life Sci; 2019 Jan 15; 217():70-80. PubMed ID: 30452972 [Abstract] [Full Text] [Related]